{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T10:46:37Z","timestamp":1788259597622,"version":"build-2803163510"},"reference-count":173,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2020,11,22]],"date-time":"2020-11-22T00:00:00Z","timestamp":1606003200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Finding A Cure for Epilepsy and Seizures (FACES) foundation and the American Epilepsy Society"},{"DOI":"10.13039\/501100012317","name":"NIHR University College London Hospitals Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012317","id-type":"DOI","asserted-by":"publisher"}]},{"name":"UK Department of Health\u2019s Comprehensive Research Centres funding scheme"},{"name":"Marvin Weil Epilepsy Research Fund"},{"DOI":"10.13039\/501100018726","name":"UK Epilepsy Society","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100018726","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Christelijke Vereniging voor de Verpleging van Lijders aan Epilepsie"},{"name":"Dutch National Epilepsy Fund (NEF","award":["15-10"],"award-info":[{"award-number":["15-10"]}]},{"DOI":"10.13039\/501100001826","name":"The Netherlands Organisation for Health Research and Development","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"crossref"}]},{"name":"NUTS Ohra Fund, Medtronic, Christelijke Vereniging voor de Verpleging van Lijders aan Epilepsie"},{"name":"AC Thomson Foundation"},{"name":"European Union\u2019s Seventh Framework Programme","award":["FP7\/2007-2013"],"award-info":[{"award-number":["FP7\/2007-2013"]}]},{"name":"European Union\u2019s Seventh Framework Programme","award":["602102"],"award-info":[{"award-number":["602102"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,3,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Systemic autoimmune disorders occur more frequently in patients with epilepsy than in the general population, suggesting shared disease mechanisms. The risk of epilepsy is elevated across the spectrum of systemic autoimmune disorders but is highest in systemic lupus erythematosus and type 1 diabetes mellitus. Vascular and metabolic factors are the most important mediators between systemic autoimmune disorders and epilepsy. Systemic immune dysfunction can also affect neuronal excitability, not only through innate immune activation and blood\u2013brain barrier dysfunction in most epilepsies but also adaptive immunity in autoimmune encephalitis. The presence of systemic autoimmune disorders in subjects with acute seizures warrants evaluation for infectious, vascular, toxic and metabolic causes of acute symptomatic seizures, but clinical signs of autoimmune encephalitis should not be missed. Immunosuppressive medications may have antiseizure properties and trigger certain drug interactions with antiseizure treatments. A better understanding of mechanisms underlying the co-existence of epilepsy and systemic autoimmune disorders is needed to guide new antiseizure and anti-epileptogenic treatments. This review aims to summarize the epidemiological evidence for systemic autoimmune disorders as comorbidities of epilepsy, explore potential immune and non-immune mechanisms, and provide practical implications on diagnostic and therapeutic approach to epilepsy in those with comorbid systemic autoimmune disorders.<\/jats:p>","DOI":"10.1093\/brain\/awaa362","type":"journal-article","created":{"date-parts":[[2020,9,28]],"date-time":"2020-09-28T19:16:29Z","timestamp":1601320589000},"page":"372-390","source":"Crossref","is-referenced-by-count":62,"title":["The association between systemic autoimmune disorders and epilepsy and its clinical implications"],"prefix":"10.1093","volume":"144","author":[{"given":"Claude","family":"Steriade","sequence":"first","affiliation":[{"name":"Department of Neurology, New York University School of Medicine, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maarten J","family":"Titulaer","sequence":"additional","affiliation":[{"name":"Department of Neurology, Erasmus University Medical Center, Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annamaria","family":"Vezzani","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josemir W","family":"Sander","sequence":"additional","affiliation":[{"name":"NIHR University College London Hospitals Biomedical Research Centre, UCL Queen Square Institute of Neurology, London WC1N 3BG, UK"},{"name":"Chalfont Centre for Epilepsy, Chalfont St Peter SL9 0RJ, Bucks, UK"},{"name":"Stichting Epilepsie Instellingen Nederland - (SEIN), Heemstede, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland D","family":"Thijs","sequence":"additional","affiliation":[{"name":"NIHR University College London Hospitals Biomedical Research Centre, UCL Queen Square Institute of Neurology, London WC1N 3BG, UK"},{"name":"Stichting Epilepsie Instellingen Nederland - (SEIN), Heemstede, The Netherlands"},{"name":"Department of Neurology, Leiden University Medical Centre, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,11,22]]},"reference":[{"key":"2021030904205522600_awaa362-B1","doi-asserted-by":"crossref","first-page":"48","DOI":"10.5152\/eurjrheum.2018.18046","article-title":"Carbamazepine-induced systemic lupus erythematosus: a case-based review","volume":"6","author":"Alvarez-Lario","year":"2019","journal-title":"Eur J Rheumatol"},{"key":"2021030904205522600_awaa362-B2","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.seizure.2018.11.012","article-title":"Seizures as a clinical manifestation in somatic autoimmune disorders","volume":"64","author":"Amanat","year":"2018","journal-title":"Seizure"},{"key":"2021030904205522600_awaa362-B3","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1136\/ard.2007.077594","article-title":"Seizures in patients with systemic lupus erythematosus: data from LUMINA, a multiethnic cohort (LUMINA LIV)","volume":"67","author":"Andrade","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"2021030904205522600_awaa362-B4","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1212\/01.WNL.0000144178.32208.4F","article-title":"Epileptic seizures in systemic lupus erythematosus","volume":"63","author":"Appenzeller","year":"2004","journal-title":"Neurology"},{"key":"2021030904205522600_awaa362-B5","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1212\/WNL.0000000000003009","article-title":"Anti-LGI1-associated cognitive impairment: presentation and long-term outcome","volume":"87","author":"Arino","year":"2016","journal-title":"Neurology"},{"key":"2021030904205522600_awaa362-B6","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s13311-013-0251-0","article-title":"Epilepsy related to developmental tumors and malformations of cortical development","volume":"11","author":"Aronica","year":"2014","journal-title":"Neurotherapeutics"},{"key":"2021030904205522600_awaa362-B7","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1177\/08830738020170110801","article-title":"Epilepsy, occipital calcifications, and oligosymptomatic celiac disease in childhood","volume":"17","author":"Arroyo","year":"2002","journal-title":"J Child Neurol"},{"key":"2021030904205522600_awaa362-B8","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s11910-018-0897-4","article-title":"Pharmacokinetic Considerations with the use of antiepileptic drugs in patients with HIV and organ transplants","volume":"18","author":"Asconape","year":"2018","journal-title":"Curr Neurol Neurosci Rep"},{"key":"2021030904205522600_awaa362-B9","doi-asserted-by":"crossref","first-page":"e244","DOI":"10.1212\/WNL.0000000000006783","article-title":"A score that predicts 1-year functional status in patients with anti-NMDA receptor encephalitis","volume":"92","author":"Balu","year":"2019","journal-title":"Neurology"},{"key":"2021030904205522600_awaa362-B10","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1007\/s11926-014-0440-9","article-title":"Vasculitis in systemic lupus erythematosus","volume":"16","author":"Barile-Fabris","year":"2014","journal-title":"Curr Rheumatol Rep"},{"key":"2021030904205522600_awaa362-B11","doi-asserted-by":"crossref","first-page":"924","DOI":"10.3174\/ajnr.A0960","article-title":"Posterior reversible encephalopathy syndrome after solid organ transplantation","volume":"29","author":"Bartynski","year":"2008","journal-title":"AJNR Am J Neuroradiol"},{"key":"2021030904205522600_awaa362-B12","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/B978-0-444-63432-0.00007-4","article-title":"Neuropathology of autoimmune encephalitides","volume":"133","author":"Bauer","year":"2016","journal-title":"Handb Clin Neurol"},{"key":"2021030904205522600_awaa362-B13","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.1007\/s00415-013-7048-2","article-title":"Cerebral FDG-PET and MRI findings in autoimmune limbic encephalitis: correlation with autoantibody types","volume":"260","author":"Baumgartner","year":"2013","journal-title":"J Neurol"},{"key":"2021030904205522600_awaa362-B14","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s00415-015-8002-2","article-title":"Neuronal autoantibodies in epilepsy patients with peri-ictal autonomic findings","volume":"263","author":"Baysal-Kirac","year":"2016","journal-title":"J Neurol"},{"key":"2021030904205522600_awaa362-B15","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1111\/j.1528-1167.2009.02285.x","article-title":"Recommendation for a definition of acute symptomatic seizure","volume":"51","author":"Beghi","year":"2010","journal-title":"Epilepsia"},{"key":"2021030904205522600_awaa362-B16","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1177\/0883073814521296","article-title":"The neurologic profile of children and adolescents with inflammatory bowel disease","volume":"30","author":"Ben-Or","year":"2015","journal-title":"J Child Neurol"},{"key":"2021030904205522600_awaa362-B17","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1468-1331.2010.03095.x","article-title":"Neurologic disorders associated with inflammatory bowel disease","volume":"18","author":"Benavente","year":"2011","journal-title":"Eur J Neurol"},{"key":"2021030904205522600_awaa362-B18","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s11910-018-0821-y","article-title":"Treating immune-related epilepsy","volume":"18","author":"Bhatia","year":"2018","journal-title":"Curr Neurol Neurosci Rep"},{"key":"2021030904205522600_awaa362-B19","doi-asserted-by":"crossref","first-page":"134","DOI":"10.5698\/1535-7511.17.3.134","article-title":"\u201cAutoimmune Epilepsy\u201d: encephalitis with autoantibodies for epileptologists","volume":"17","author":"Bien","year":"2017","journal-title":"Epilepsy Curr"},{"key":"2021030904205522600_awaa362-B20","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1093\/brain\/awy109","article-title":"Distinct HLA associations of LGI1 and CASPR2-antibody diseases","volume":"141","author":"Binks","year":"2018","journal-title":"Brain"},{"key":"2021030904205522600_awaa362-B21","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.3389\/fimmu.2017.01452","article-title":"The vagus nerve in the neuro-immune axis: implications in the pathology of the gastrointestinal tract","volume":"8","author":"Bonaz","year":"2017","journal-title":"Front Immunol"},{"key":"2021030904205522600_awaa362-B22","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.ejpn.2016.03.005","article-title":"Autoantibodies to neuronal antigens in children with focal epilepsy and no prima facie signs of encephalitis","volume":"20","author":"Borusiak","year":"2016","journal-title":"Eur J Paediatr Neurol"},{"key":"2021030904205522600_awaa362-B23","doi-asserted-by":"crossref","first-page":"e9698","DOI":"10.1371\/journal.pone.0009698","article-title":"Anti transglutaminase antibodies cause ataxia in mice","volume":"5","author":"Boscolo","year":"2010","journal-title":"PLoS One"},{"key":"2021030904205522600_awaa362-B24","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1111\/epi.12127","article-title":"Prevalence of neurologic autoantibodies in cohorts of patients with new and established epilepsy","volume":"54","author":"Brenner","year":"2013","journal-title":"Epilepsia"},{"key":"2021030904205522600_awaa362-B26","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1002\/mds.22821","article-title":"Neurological symptoms in patients with biopsy proven celiac disease","volume":"24","author":"B\u00fcrk","year":"2009","journal-title":"Mov Disord"},{"key":"2021030904205522600_awaa362-B27","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S2352-4642(19)30055-0","article-title":"The effect of type 1 diabetes on the developing brain","volume":"3","author":"Cameron","year":"2019","journal-title":". Lancet Child Adolescent Health"},{"key":"2021030904205522600_awaa362-B28","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.2337\/dc13-1904","article-title":"Neurological consequences of diabetic ketoacidosis at initial presentation of type 1 diabetes in a prospective cohort study of children","volume":"37","author":"Cameron","year":"2014","journal-title":"Diabetes Care"},{"key":"2021030904205522600_awaa362-B29","doi-asserted-by":"crossref","first-page":"577142","DOI":"10.1016\/j.jneuroim.2019.577142","article-title":"Tocilizumab in pediatric refractory status epilepticus and acute epilepsy: experience in two patients","volume":"340","author":"Cantar\u00edn-Extremera","year":"2020","journal-title":"J Neuroimmunol"},{"key":"2021030904205522600_awaa362-B30","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.eplepsyres.2016.12.010","article-title":"Epilepsy surgery in drug resistant temporal lobe epilepsy associated with neuronal antibodies","volume":"129","author":"Carreno","year":"2017","journal-title":"Epilepsy Res"},{"key":"2021030904205522600_awaa362-B31","doi-asserted-by":"crossref","first-page":"e1485","DOI":"10.1097\/MD.0000000000001485","article-title":"A large-scale study indicates increase in the risk of epilepsy in patients with different risk factors, including rheumatoid arthritis","volume":"94","author":"Chang","year":"2015","journal-title":"Medicine (Baltimore"},{"key":"2021030904205522600_awaa362-B32","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1136\/bmj.2.6132.250","article-title":"Increased prevalence of epilepsy in coeliac disease","volume":"2","author":"Chapman Rwl","year":"1978","journal-title":"BMJ"},{"key":"2021030904205522600_awaa362-B33","doi-asserted-by":"crossref","first-page":"6897","DOI":"10.1007\/s12035-015-9560-0","article-title":"Posterior reversible encephalopathy syndrome after transplantation: a review","volume":"53","author":"Chen","year":"2016","journal-title":"Mol Neurobiol"},{"key":"2021030904205522600_awaa362-B34","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1007\/s00125-016-3929-0","article-title":"Risk of epilepsy in type 1 diabetes mellitus: a population-based cohort study","volume":"59","author":"Chou","year":"2016","journal-title":"Diabetologia"},{"key":"2021030904205522600_awaa362-B35","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1093\/qjmed\/91.4.303","article-title":"Coeliac disease and epilepsy","volume":"91","author":"Cronin","year":"1998","journal-title":"QJM"},{"key":"2021030904205522600_awaa362-B36","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1007\/s00125-016-4142-x","article-title":"Type 1 diabetes mellitus and risk of incident epilepsy: a population-based, open-cohort study","volume":"60","author":"Dafoulas","year":"2017","journal-title":"Diabetologia"},{"key":"2021030904205522600_awaa362-B37","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1007\/s00381-014-2387-6","article-title":"Prevalence of resistant occipital lobe epilepsy associated with celiac disease in children. Child's nervous system: chNS: official journal of the International Society for","volume":"30","author":"Dai","year":"2014","journal-title":"Childs Nerv Syst"},{"key":"2021030904205522600_awaa362-B38","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1177\/08830738060210010301","article-title":"Latent and potential celiac disease in epileptic Turkish children","volume":"21","author":"Dalgic","year":"2006","journal-title":"J Child Neurol"},{"key":"2021030904205522600_awaa362-B39","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1056\/NEJMra1708712","article-title":"Antibody-mediated encephalitis","volume":"378","author":"Dalmau","year":"2018","journal-title":"N Engl J Med"},{"key":"2021030904205522600_awaa362-B40","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.92.15_supplement.S11.001","volume-title":"Neuronal antibodies in a prospective, multicenter cohort of patients with focal epilepsy of unknown origin","author":"de Bruijn","year":"2019"},{"key":"2021030904205522600_awaa362-B41","doi-asserted-by":"crossref","first-page":"e2185","DOI":"10.1212\/WNL.0000000000007475","article-title":"Evaluation of seizure treatment in anti-LGI1, anti-NMDAR, and anti-GABABR encephalitis","volume":"92","author":"de Bruijn","year":"2019","journal-title":"Neurology"},{"key":"2021030904205522600_awaa362-B42","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.2337\/dc14-1720","article-title":"Type 1 diabetes mellitus and cardiovascular disease: a scientific statement from the American Heart Association and American Diabetes Association","volume":"37","author":"de Ferranti","year":"2014","journal-title":"Diabetes Care"},{"key":"2021030904205522600_awaa362-B43","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1038\/nm1101-1189","article-title":"A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus","volume":"7","author":"DeGiorgio","year":"2001","journal-title":"Nat Med"},{"key":"2021030904205522600_awaa362-B44","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s12974-018-1063-2","article-title":"Systemic autoinflammation with intractable epilepsy managed with interleukin-1 blockade","volume":"15","author":"DeSena","year":"2018","journal-title":"J Neuroinflammation"},{"key":"2021030904205522600_awaa362-B45","doi-asserted-by":"crossref","first-page":"62","DOI":"10.5698\/1535-7597-13.2.62","article-title":"Epilepsy associated with systemic autoimmune disorders","volume":"13","author":"Devinsky","year":"2013","journal-title":"Epilepsy Curr"},{"key":"2021030904205522600_awaa362-B46","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1111\/epi.12628","article-title":"IL-1beta associations with posttraumatic epilepsy development: a genetics and biomarker cohort study","volume":"55","author":"Diamond","year":"2014","journal-title":"Epilepsia"},{"key":"2021030904205522600_awaa362-B47","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/epi4.12317","article-title":"Therapeutic effect of Anakinra in the relapsing chronic phase of febrile infection-related epilepsy syndrome","volume":"4","author":"Dilena","year":"2019","journal-title":"Epilepsia Open"},{"key":"2021030904205522600_awaa362-B48","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1016\/S0140-6736(18)31320-5","article-title":"Type 1 diabetes","volume":"391","author":"DiMeglio","year":"2018","journal-title":"Lancet"},{"key":"2021030904205522600_awaa362-B49","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1001\/jamaneurol.2016.5429","article-title":"Neurological autoantibody prevalence in epilepsy of unknown etiology","volume":"74","author":"Dubey","year":"2017","journal-title":"JAMA Neurol"},{"key":"2021030904205522600_awaa362-B50","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/ana.25655","article-title":"Randomized placebo-controlled trial of intravenous immunoglobulin in autoimmune LGI1\/CASPR2 epilepsy","volume":"87","author":"Dubey","year":"2020","journal-title":"Ann Neurol"},{"key":"2021030904205522600_awaa362-B51","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1002\/ajmg.b.32036","article-title":"Mutations in NRXN1 in a family multiply affected with brain disorders: NRXN1 mutations and brain disorders","volume":"159b","author":"Duong","year":"2012","journal-title":"Am J Med Genet"},{"key":"2021030904205522600_awaa362-B52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jns.2011.07.053","article-title":"Epilepsy and Behcet's disease: cortical and hippocampal involvement in Brazilian patients","volume":"309","author":"Dutra","year":"2011","journal-title":"J Neurol Sci"},{"key":"2021030904205522600_awaa362-B53","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1097\/00007611-199706000-00005","article-title":"Neurologic and neuropsychiatric complications of Crohn's disease","volume":"90","author":"Elsehety","year":"1997","journal-title":"South Med J"},{"key":"2021030904205522600_awaa362-B54","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1136\/archdischild-2014-307654","article-title":"Chronic comorbidities in children with type 1 diabetes: a population-based cohort study","volume":"100","author":"Fazeli Farsani","year":"2015","journal-title":"Arch Dis Child"},{"key":"2021030904205522600_awaa362-B55","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1001\/jamaneurol.2016.4226","article-title":"Evaluation of cognitive deficits and structural hippocampal damage in encephalitis with leucine-rich, glioma-inactivated 1 antibodies","volume":"74","author":"Finke","year":"2017","journal-title":"JAMA Neurol"},{"key":"2021030904205522600_awaa362-B56","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/j.0013-9580.2005.66104.x","article-title":"Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE)","volume":"46","author":"Fisher","year":"2005","journal-title":"Epilepsia"},{"key":"2021030904205522600_awaa362-B57","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.3389\/fneur.2018.01001","article-title":"Antiphospholipid syndrome and the neurologist: from pathogenesis to therapy","volume":"9","author":"Fleetwood","year":"2018","journal-title":"Front Neurol"},{"key":"2021030904205522600_awaa362-B58","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/978-1-4939-2895-8_8","article-title":"Glucocorticoid-induced osteoporosis","volume":"872","author":"Frenkel","year":"2015","journal-title":"Adv Exp Med Biol"},{"key":"2021030904205522600_awaa362-B59","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/nrendo.2014.170","article-title":"Hypoglycaemia in diabetes mellitus: epidemiology and clinical implications","volume":"10","author":"Frier","year":"2014","journal-title":"Nat Rev Endocrinol"},{"key":"2021030904205522600_awaa362-B60","doi-asserted-by":"crossref","first-page":"521","DOI":"10.3389\/fimmu.2017.00521","article-title":"Thyroid autoimmunity: role of anti-thyroid antibodies in thyroid and extra-thyroidal diseases","volume":"8","author":"Frohlich","year":"2017","journal-title":"Front Immunol"},{"key":"2021030904205522600_awaa362-B61","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/ana.24979","article-title":"Expanded phenotypes and outcomes among 256 LGI1\/CASPR2-IgG-positive patients","volume":"82","author":"Gadoth","year":"2017","journal-title":"Ann Neurol"},{"key":"2021030904205522600_awaa362-B62","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/pedi.12346","article-title":"Epilepsy and behavioral changes, type 1 diabetes mellitus and a high titer of glutamic acid decarboxylase antibodies","volume":"17","author":"Ganelin-Cohen","year":"2016","journal-title":"Pediatr Diabetes"},{"key":"2021030904205522600_awaa362-B63","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1212\/WNL.0000000000001940","article-title":"New-onset refractory status epilepticus: etiology, clinical features, and outcome","volume":"85","author":"Gaspard","year":"2015","journal-title":"Neurology"},{"key":"2021030904205522600_awaa362-B64","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1177\/0148607110384118","article-title":"Vitamin B6 deficiency: a potential cause of refractory seizures in adults","volume":"35","author":"Gerlach","year":"2011","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"2021030904205522600_awaa362-B65","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1684\/epd.2017.0946","article-title":"Refractory chronic epilepsy associated with neuronal auto-antibodies: could perisylvian semiology be a clue?","volume":"19","author":"Gillinder","year":"2017","journal-title":"Epileptic Disord"},{"key":"2021030904205522600_awaa362-B66","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.pediatrneurol.2009.02.009","article-title":"Celiac disease-related antibodies in Italian children with epilepsy","volume":"41","author":"Giordano","year":"2009","journal-title":"Pediatr Neurol"},{"key":"2021030904205522600_awaa362-B67","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.2337\/db11-1286","article-title":"Effects of hyperglycemia and effects of ketosis on cerebral perfusion, cerebral water distribution, and cerebral metabolism","volume":"61","author":"Glaser","year":"2012","journal-title":"Diabetes"},{"key":"2021030904205522600_awaa362-B68","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.braindev.2004.05.003","article-title":"Coeliac disease, epilepsy and cerebral calcifications","volume":"27","author":"Gobbi","year":"2005","journal-title":"Brain Devt"},{"key":"2021030904205522600_awaa362-B69","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/0140-6736(92)91766-2","article-title":"Coeliac disease, epilepsy, and cerebral calcifications. The Italian Working Group on Coeliac Disease and Epilepsy","volume":"340","author":"Gobbi","year":"1992","journal-title":"Lancet"},{"key":"2021030904205522600_awaa362-B70","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1159\/000121423","article-title":"Clinical description of seizures in patients with systemic lupus erythematosus","volume":"59","author":"Gonzalez-Duarte","year":"2008","journal-title":"Eur Neurol"},{"key":"2021030904205522600_awaa362-B71","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","article-title":"A clinical approach to diagnosis of autoimmune encephalitis","volume":"15","author":"Graus","year":"2016","journal-title":"Lancet Neurol"},{"key":"2021030904205522600_awaa362-B72","doi-asserted-by":"crossref","first-page":"e0121364","DOI":"10.1371\/journal.pone.0121364","article-title":"Antibodies to inhibitory synaptic proteins in neurological syndromes associated with glutamic acid decarboxylase autoimmunity","volume":"10","author":"Gresa-Arribas","year":"2015","journal-title":"PLoS One"},{"key":"2021030904205522600_awaa362-B73","doi-asserted-by":"crossref","first-page":"130","DOI":"10.3389\/fncel.2016.00130","article-title":"Anti-GAD65 containing cerebrospinal fluid does not alter GABAergic transmission","volume":"10","author":"Hackert","year":"2016","journal-title":"Front Cell Neurosci"},{"key":"2021030904205522600_awaa362-B74","first-page":"1459","article-title":"Neuropsychiatric syndromes in patients with systemic lupus erythematosus and rheumatoid arthritis","volume":"32","author":"Hanly","year":"2005","journal-title":"J Rheumatol"},{"key":"2021030904205522600_awaa362-B75","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1136\/jnnp.45.8.729","article-title":"Epilepsy and coeliac disease","volume":"45","author":"Hanly","year":"1982","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2021030904205522600_awaa362-B76","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1136\/annrheumdis-2011-201089","article-title":"Seizure disorders in systemic lupus erythematosus results from an international, prospective, inception cohort study","volume":"71","author":"Hanly","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"2021030904205522600_awaa362-B77","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1136\/ard.2008.098301","article-title":"Neuropsychiatric syndromes in patients with systemic lupus erythematosus and primary Sjogren syndrome: a comparative population-based study","volume":"68","author":"Harboe","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"2021030904205522600_awaa362-B78","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1002\/art.1780370418","article-title":"Association between antiphospholipid antibodies and epilepsy in patients with systemic lupus erythematosus","volume":"37","author":"Herranz","year":"1994","journal-title":"Arthritis Rheum"},{"key":"2021030904205522600_awaa362-B79","doi-asserted-by":"crossref","first-page":"5269","DOI":"10.1038\/s41467-018-07524-z","article-title":"Genome-wide mega-analysis identifies 16 loci and highlights diverse biological mechanisms in the common epilepsies","volume":"9","year":"2018","journal-title":"Nat Commun"},{"key":"2021030904205522600_awaa362-B80","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.autrev.2018.01.025","article-title":"Antiphospholipid antibodies in epilepsy: a systematic review and meta-analysis","volume":"17","author":"Islam","year":"2018","journal-title":"Autoimmun Rev"},{"key":"2021030904205522600_awaa362-B81","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1212\/CPJ.0000000000000349","article-title":"Depression in epilepsy, migraine, and multiple sclerosis: epidemiology and how to screen for it","volume":"7","author":"Jette","year":"2017","journal-title":"Neurol Clin Pract"},{"key":"2021030904205522600_awaa362-B82","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1007\/s00415-018-9025-2","article-title":"Gluten sensitivity and epilepsy: a systematic review","volume":"266","author":"Julian","year":"2018","journal-title":"J Neurol"},{"key":"2021030904205522600_awaa362-B83","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1002\/ana.25374","article-title":"Tocilizumab treatment for new onset refractory status epilepticus","volume":"84","author":"Jun","year":"2018","journal-title":"Ann Neurol"},{"key":"2021030904205522600_awaa362-B84","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.eplepsyres.2016.12.006","article-title":"Investigation of neuronal auto-antibodies in systemic lupus erythematosus patients with epilepsy","volume":"129","author":"Karaaslan","year":"2017","journal-title":"Epilepsy Res"},{"key":"2021030904205522600_awaa362-B85","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.eplepsyres.2015.05.008","article-title":"Type 1 diabetes mellitus in people with pharmacoresistant epilepsy: prevalence and clinical characteristics","volume":"115","author":"Keezer","year":"2015","journal-title":"Epilepsy Res"},{"key":"2021030904205522600_awaa362-B86","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S1474-4422(15)00225-2","article-title":"Comorbidities of epilepsy: current concepts and future perspectives","volume":"15","author":"Keezer","year":"2016","journal-title":"Lancet Neurol"},{"key":"2021030904205522600_awaa362-B87","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1002\/ana.24806","article-title":"Febrile infection-related epilepsy syndrome treated with anakinra","volume":"80","author":"Kenney-Jung","year":"2016","journal-title":"Ann Neurol"},{"key":"2021030904205522600_awaa362-B88","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1208\/s12248-013-9495-1","article-title":"Therapeutic protein drug-drug interactions: navigating the knowledge gaps-highlights from the 2012 AAPS NBC Roundtable and IQ Consortium\/FDA workshop","volume":"15","author":"Kenny","year":"2013","journal-title":"AAPS J"},{"key":"2021030904205522600_awaa362-B89","doi-asserted-by":"crossref","first-page":"E21","DOI":"10.1542\/peds.108.2.e21","article-title":"Brain white-matter lesions in celiac disease: a prospective study of 75 diet-treated patients","volume":"108","author":"Kieslich","year":"2001","journal-title":"Pediatrics"},{"key":"2021030904205522600_awaa362-B90","doi-asserted-by":"crossref","first-page":"7711","DOI":"10.1038\/s41598-017-07394-3","article-title":"TGFbeta signaling is associated with changes in inflammatory gene expression and perineuronal net degradation around inhibitory neurons following various neurological insults","volume":"7","author":"Kim","year":"2017","journal-title":"Sci Rep"},{"key":"2021030904205522600_awaa362-B91","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/ana.24860","article-title":"Anti-LGI1 encephalitis is associated with unique HLA subtypes","volume":"81","author":"Kim","year":"2017","journal-title":"Ann Neurol"},{"key":"2021030904205522600_awaa362-B92","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s11239-014-1129-7","article-title":"Thromboembolic complications in inflammatory bowel disease","volume":"39","author":"Kohoutova","year":"2015","journal-title":"J Thromb Thrombolysis"},{"key":"2021030904205522600_awaa362-B93","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1111\/ene.13564","article-title":"Persistent mucosal damage and risk of epilepsy in people with celiac disease","volume":"25","author":"Kurien","year":"2018","journal-title":"Eur J Neurol"},{"key":"2021030904205522600_awaa362-B94","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.seizure.2015.01.013","article-title":"Epileptic seizures in Neuro-Behcet disease: why some patients develop seizure and others not?","volume":"26","author":"Kutlu","year":"2015","journal-title":"Seizure"},{"key":"2021030904205522600_awaa362-B95","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1046\/j.1528-1157.2001.45700.x","article-title":"Silent celiac disease in patients with childhood localization-related epilepsies","volume":"42","author":"Labate","year":"2001","journal-title":"Epilepsia"},{"key":"2021030904205522600_awaa362-B96","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1111\/epi.13387","article-title":"Anti-tumor necrosis factor alpha therapy (adalimumab) in Rasmussen's encephalitis: an open pilot study","volume":"57","author":"Lagarde","year":"2016","journal-title":"Epilepsia"},{"key":"2021030904205522600_awaa362-B97","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.autrev.2016.09.008","article-title":"Steroid-responsive encephalopathy associated with autoimmune thyroiditis (SREAT): characteristics, treatment and outcome in 251 cases from the literature","volume":"15","author":"Laurent","year":"2016","journal-title":"Autoimmun Rev"},{"key":"2021030904205522600_awaa362-B98","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0140-6736(17)31796-8","article-title":"Coeliac disease","volume":"391","author":"Lebwohl","year":"2018","journal-title":"Lancet"},{"key":"2021030904205522600_awaa362-B99","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1212\/WNL.0000000000002635","article-title":"Rituximab treatment for autoimmune limbic encephalitis in an institutional cohort","volume":"86","author":"Lee","year":"2016","journal-title":"Neurology"},{"key":"2021030904205522600_awaa362-B100","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/S2215-0366(17)30043-3","article-title":"Serum neuronal cell-surface antibodies in first-episode psychosis","volume":"4","author":"Leypoldt","year":"2017","journal-title":"Lancet Psychiatry"},{"key":"2021030904205522600_awaa362-B101","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1016\/S0140-6736(14)60128-8","article-title":"Systemic lupus erythematosus","volume":"384","author":"Lisnevskaia","year":"2014","journal-title":"Lancet"},{"key":"2021030904205522600_awaa362-B102","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/ane.12556","article-title":"Initial serum thyroid peroxidase antibodies and long-term outcomes in SREAT","volume":"134","author":"Litmeier","year":"2016","journal-title":"Acta Neurol Scand"},{"key":"2021030904205522600_awaa362-B103","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1212\/WNL.45.3.416","article-title":"Neurologic aspects of inflammatory Bowel disease","volume":"45","author":"Lossos","year":"1995","journal-title":"Neurology"},{"key":"2021030904205522600_awaa362-B104","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1212\/WNL.0b013e3182544728","article-title":"Increased risk of epilepsy in biopsy-verified celiac disease: a population-based cohort study","volume":"78","author":"Ludvigsson","year":"2012","journal-title":"Neurology"},{"key":"2021030904205522600_awaa362-B105","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1159\/000050802","article-title":"Association between coeliac disease, epilepsy and brain atrophy","volume":"46","author":"Luostarinen","year":"2001","journal-title":"Eur Neurol"},{"key":"2021030904205522600_awaa362-B106","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1093\/rheumatology\/kex019","article-title":"Value of multidisciplinary reassessment in attribution of neuropsychiatric events to systemic lupus erythematosus: prospective data from the Leiden NPSLE cohort","volume":"56","author":"Magro-Checa","year":"2017","journal-title":"Rheumatology (Oxford"},{"key":"2021030904205522600_awaa362-B107","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.seizure.2015.05.017","article-title":"Treatment of immune-mediated temporal lobe epilepsy with GAD antibodies","volume":"30","author":"Malter","year":"2015","journal-title":"Seizure"},{"key":"2021030904205522600_awaa362-B108","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jns.2018.11.014","article-title":"Cerebral folate deficiency in adults: a heterogeneous potentially treatable condition","volume":"396","author":"Masingue","year":"2019","journal-title":"J Neurol Sci"},{"key":"2021030904205522600_awaa362-B109","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.ejpn.2018.12.006","article-title":"Epilepsy in children with type 1 diabetes mellitus: pathophysiological basis and clinical hallmarks","volume":"23","author":"Mastrangelo","year":"2019","journal-title":"Eur J Paediatr Neurol"},{"key":"2021030904205522600_awaa362-B110","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.pediatrneurol.2006.11.011","article-title":"Increased prevalence of silent celiac disease among Greek epileptic children","volume":"36","author":"Mavroudi","year":"2007","journal-title":"Pediatr Neurol"},{"key":"2021030904205522600_awaa362-B111","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/ana.20727","article-title":"An association between type 1 diabetes and idiopathic generalized epilepsy","volume":"59","author":"McCorry","year":"2006","journal-title":"Ann Neurol"},{"key":"2021030904205522600_awaa362-B112","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12950-016-0140-5","article-title":"Electric stimulation of the vagus nerve reduced mouse neuroinflammation induced by lipopolysaccharide","volume":"13","author":"Meneses","year":"2016","journal-title":"J Inflamm"},{"key":"2021030904205522600_awaa362-B113","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1212\/01.WNL.0000165959.98370.D5","article-title":"Factors at diagnosis predict subsequent occurrence of seizures in systemic lupus erythematosus","volume":"64","author":"Mikdashi","year":"2005","journal-title":"Neurology"},{"key":"2021030904205522600_awaa362-B114","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1093\/brain\/awx070","article-title":"Focal CA3 hippocampal subfield atrophy following LGI1 VGKC-complex antibody limbic encephalitis","volume":"140","author":"Miller","year":"2017","journal-title":"Brain"},{"key":"2021030904205522600_awaa362-B115","doi-asserted-by":"crossref","first-page":"2913297","DOI":"10.1155\/2017\/2913297","article-title":"Pathogenic roles of glutamic acid decarboxylase 65 autoantibodies in cerebellar ataxias","volume":"2017","author":"Mitoma","year":"2017","journal-title":"J Immunol Res"},{"key":"2021030904205522600_awaa362-B116","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J Thromb Haemost"},{"key":"2021030904205522600_awaa362-B117","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.autrev.2016.01.014","article-title":"Hashimoto's encephalopathy: a rare proteiform disorder","volume":"15","author":"Montagna","year":"2016","journal-title":"Autoimmun Rev"},{"key":"2021030904205522600_awaa362-B118","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s00296-014-3097-9","article-title":"Frequent involvement of central nervous system in primary Sjogren syndrome","volume":"35","author":"Moreira","year":"2014","journal-title":"Rheumatol Int"},{"key":"2021030904205522600_awaa362-B119","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1002\/ana.25216","article-title":"Genetic predisposition in anti-LGI1 and anti-NMDA receptor encephalitis","volume":"83","author":"Mueller","year":"2018","journal-title":"Ann Neurol"},{"key":"2021030904205522600_awaa362-B120","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000696","article-title":"Neurologic syndromes related to anti-GAD65: clinical and serologic response to treatment","volume":"7","author":"Mu\u00f1oz-Lopetegi","year":"2020","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"2021030904205522600_awaa362-B121","year":"2014"},{"key":"2021030904205522600_awaa362-B122","doi-asserted-by":"crossref","first-page":"e152","DOI":"10.1111\/epi.14534","article-title":"Mesial temporal lobe epilepsy with hippocampal sclerosis is infrequently associated with neuronal autoantibodies","volume":"59","author":"Nobrega","year":"2018","journal-title":"Epilepsia"},{"key":"2021030904205522600_awaa362-B123","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/nyas.12935","article-title":"Toward a better understanding of the central consequences of intestinal inflammation","volume":"1351","author":"Nyuyki","year":"2015","journal-title":"Ann NY Acad Sci"},{"key":"2021030904205522600_awaa362-B124","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1111\/j.1440-1754.2008.01387.x","article-title":"Does epilepsy occur more frequently in children with Type 1 diabetes?","volume":"44","author":"O'Connell","year":"2008","journal-title":"J Paediatr Child Health"},{"key":"2021030904205522600_awaa362-B125","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.eplepsyres.2013.10.013","article-title":"Seizure-induced disinhibition of the HPA axis increases seizure susceptibility","volume":"108","author":"O'Toole","year":"2014","journal-title":"Epilepsy Res"},{"key":"2021030904205522600_awaa362-B126","doi-asserted-by":"crossref","first-page":"18161","DOI":"10.1523\/JNEUROSCI.3506-13.2013","article-title":"Autoantibodies to epilepsy-related LGI1 in limbic encephalitis neutralize LGI1-ADAM22 interaction and reduce synaptic AMPA receptors","volume":"33","author":"Ohkawa","year":"2013","journal-title":"J Neurosci"},{"key":"2021030904205522600_awaa362-B127","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/ibd.20304","article-title":"Peripheral neuropathy and neurological disorders in an unselected Brazilian population-based cohort of IBD patients","volume":"14","author":"Oliveira","year":"2008","journal-title":"Inflamm Bowel Dis"},{"key":"2021030904205522600_awaa362-B128","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1016\/j.cell.2018.04.027","article-title":"The gut microbiota mediates the anti-seizure effects of the ketogenic diet","volume":"173","author":"Olson","year":"2018","journal-title":"Cell"},{"key":"2021030904205522600_awaa362-B129","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1001\/jamaneurol.2014.188","article-title":"Population-level evidence for an autoimmune etiology of epilepsy","volume":"71","author":"Ong","year":"2014","journal-title":"JAMA Neurol"},{"key":"2021030904205522600_awaa362-B130","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1093\/brain\/awx117","article-title":"Targeting oxidative stress improves disease outcomes in a rat model of acquired epilepsy","volume":"140","author":"Pauletti","year":"2017","journal-title":"Brain"},{"key":"2021030904205522600_awaa362-B131","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1136\/jnnp.2008.148221","article-title":"Hippocampal sclerosis in refractory temporal lobe epilepsy is associated with gluten sensitivity","volume":"80","author":"Peltola","year":"2009","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2021030904205522600_awaa362-B132","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1111\/j.0013-9580.2004.54104.x","article-title":"The prevalence of epilepsy in patients with celiac disease","volume":"45","author":"Pengiran Tengah","year":"2004","journal-title":"Epilepsia"},{"key":"2021030904205522600_awaa362-B133","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/S1474-4422(12)70153-9","article-title":"Adverse effects of antiepileptic drugs","volume":"11","author":"Perucca","year":"2012","journal-title":"Lancet Neurol"},{"key":"2021030904205522600_awaa362-B134","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/ana.23898","article-title":"Maternal immune activation promotes hippocampal kindling epileptogenesis in mice","volume":"74","author":"Pineda","year":"2013","journal-title":"Ann Neurol"},{"key":"2021030904205522600_awaa362-B135","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S1474-4422(15)00248-3","article-title":"Development of epilepsy after ischaemic stroke","volume":"15","author":"Pitkanen","year":"2016","journal-title":"Lancet Neurol"},{"key":"2021030904205522600_awaa362-B136","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/ana.24721","article-title":"Ephrin-B2 prevents N-methyl-D-aspartate receptor antibody effects on memory and neuroplasticity","volume":"80","author":"Planaguma","year":"2016","journal-title":"Ann Neurol"},{"key":"2021030904205522600_awaa362-B137","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.ajhg.2011.07.006","article-title":"Microcephaly with simplified gyration, epilepsy, and infantile diabetes linked to inappropriate apoptosis of neural progenitors","volume":"89","author":"Poulton","year":"2011","journal-title":"Am J Hum Genet"},{"key":"2021030904205522600_awaa362-B138","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1001\/archneurol.2011.2985","article-title":"Autoimmune epilepsy: clinical characteristics and response to immunotherapy","volume":"69","author":"Quek","year":"2012","journal-title":"Arch Neurol"},{"key":"2021030904205522600_awaa362-B139","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.seizure.2012.01.003","article-title":"Study of prevalence of epilepsy in children with type 1 diabetes mellitus","volume":"21","author":"Ramakrishnan","year":"2012","journal-title":"Seizure"},{"key":"2021030904205522600_awaa362-B140","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1177\/0961203307086639","article-title":"Time to seizure occurrence and damage in PROFILE, a multi-ethnic systemic lupus erythematosus cohort","volume":"17","author":"Ramsey-Goldman","year":"2008","journal-title":"Lupus"},{"key":"2021030904205522600_awaa362-B141","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.yebeh.2005.01.007","article-title":"Celiac disease-related antibodies in an epilepsy cohort and matched reference population","volume":"6","author":"Ranua","year":"2005","journal-title":"Epilepsy Behav"},{"key":"2021030904205522600_awaa362-B142","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1212\/WNL.0000000000003424","article-title":"Parental rheumatoid arthritis and childhood epilepsy: a nationwide cohort study","volume":"87","author":"Rom","year":"2016","journal-title":"Neurology"},{"key":"2021030904205522600_awaa362-B143","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.nbd.2015.07.003","article-title":"GABAA currents are decreased by IL-1beta in epileptogenic tissue of patients with temporal lobe epilepsy: implications for ictogenesis","volume":"82","author":"Roseti","year":"2015","journal-title":"Neurobiol Dis"},{"key":"2021030904205522600_awaa362-B144","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.jpeds.2007.06.042","article-title":"Low prevalence of neurologic and psychiatric manifestations in children with gluten sensitivity","volume":"152","author":"Ruggieri","year":"2008","journal-title":"J Pediatr"},{"key":"2021030904205522600_awaa362-B145","first-page":"740","author":"Sa","year":"2019"},{"key":"2021030904205522600_awaa362-B146","first-page":"985","article-title":"Neuropsychiatric manifestations in systemic lupus erythematosus: prevalence and association with antiphospholipid antibodies","volume":"30","author":"Sanna","year":"2003","journal-title":"J Rheumatol"},{"key":"2021030904205522600_awaa362-B147","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.jpeds.2011.09.054","article-title":"Association of epilepsy and type 1 diabetes mellitus in children and adolescents: is there an increased risk for diabetic ketoacidosis?","volume":"160","author":"Schober","year":"2012","journal-title":"J Pediatr"},{"key":"2021030904205522600_awaa362-B148","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.0013-9580.2004.00703.x","article-title":"Pharmacorefractory status epilepticus due to low vitamin B6 levels during pregnancy","volume":"45","author":"Schulze-Bonhage","year":"2004","journal-title":"Epilepsia"},{"key":"2021030904205522600_awaa362-B149","first-page":"2235","volume-title":"Acta Paediatr","author":"Sillanpaa","year":"2019"},{"key":"2021030904205522600_awaa362-B150","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/MCC.0000000000000397","article-title":"Central nervous system infections in immunocompromised patients","volume":"23","author":"Sonneville","year":"2017","journal-title":"Curr Opin Crit Care"},{"key":"2021030904205522600_awaa362-B151","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.seizure.2018.06.021","article-title":"Electroclinical features of seizures associated with autoimmune encephalitis","volume":"60","author":"Steriade","year":"2018","journal-title":"Seizure"},{"key":"2021030904205522600_awaa362-B152","doi-asserted-by":"crossref","first-page":"ii76","DOI":"10.1136\/annrheumdis-2012-202369","article-title":"Neuropsychiatric manifestations in patients with systemic lupus erythematosus: epidemiology and radiology pointing to an immune-mediated cause","volume":"72","author":"Steup-Beekman","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"2021030904205522600_awaa362-B153","doi-asserted-by":"crossref","first-page":"500","DOI":"10.2337\/diabetes.54.2.500","article-title":"Hypoglycemia induces transient neurogenesis and subsequent progenitor cell loss in the rat hippocampus","volume":"54","author":"Suh","year":"2005","journal-title":"Diabetes"},{"key":"2021030904205522600_awaa362-B154","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0140-6736(18)32596-0","article-title":"Epilepsy in adults","volume":"393","author":"Thijs","year":"2019","journal-title":"Lancet"},{"key":"2021030904205522600_awaa362-B155","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1093\/brain\/awx323","article-title":"The importance of early immunotherapy in patients with faciobrachial dystonic seizures","volume":"141","author":"Thompson","year":"2018","journal-title":"Brain"},{"key":"2021030904205522600_awaa362-B156","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1474-4422(12)70310-1","article-title":"Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study","volume":"12","author":"Titulaer","year":"2013","journal-title":"Lancet Neurol"},{"key":"2021030904205522600_awaa362-B157","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1212\/WNL.0000000000000383","article-title":"Utility of an immunotherapy trial in evaluating patients with presumed autoimmune epilepsy","volume":"82","author":"Toledano","year":"2014","journal-title":"Neurology"},{"key":"2021030904205522600_awaa362-B158","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/S1474-4422(18)30107-8","article-title":"Comparative risk of major congenital malformations with eight different antiepileptic drugs: a prospective cohort study of the EURAP registry","volume":"17","author":"Tomson","year":"2018","journal-title":"Lancet Neurol"},{"key":"2021030904205522600_awaa362-B159","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.neuroscience.2019.04.036","article-title":"The water diffusion of brain following hypoglycemia in rats - a study with diffusion weighted imaging and neuropathologic analysis","volume":"409","author":"Tong","year":"2019","journal-title":"Neuroscience"},{"key":"2021030904205522600_awaa362-B160","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1111\/epi.12012","article-title":"Mesial temporal lobe epilepsy as a neuropsychiatric syndrome of systemic lupus erythematosus","volume":"54","author":"Toyota","year":"2013","journal-title":"Epilepsia"},{"key":"2021030904205522600_awaa362-B161","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.2147\/NDT.S64323","article-title":"Risk of epilepsy in patients with systemic lupus erythematosus \u2013 a retrospective cohort study","volume":"10","author":"Tsai","year":"2014","journal-title":"Neuropsychiatr Dis Treat"},{"key":"2021030904205522600_awaa362-B162","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1007\/s00415-004-0550-9","article-title":"Neurological abnormalities associated with celiac disease","volume":"251","author":"Vaknin","year":"2004","journal-title":"J Neurol"},{"key":"2021030904205522600_awaa362-B163","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/ana.24858","article-title":"Anti-LGI1 encephalitis is strongly associated with HLA-DR7 and HLA-DRB4","volume":"81","author":"van Sonderen","year":"2017","journal-title":"Ann Neurol"},{"key":"2021030904205522600_awaa362-B164","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S1474-4422(13)70260-6","article-title":"Rasmussen's encephalitis: clinical features, pathobiology, and treatment advances","volume":"13","author":"Varadkar","year":"2014","journal-title":"Lancet Neurol"},{"key":"2021030904205522600_awaa362-B165","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/s41582-019-0217-x","article-title":"Neuroinflammatory pathways as treatment targets and biomarkers in epilepsy","volume":"15","author":"Vezzani","year":"2019","journal-title":"Nat Rev Neurol"},{"key":"2021030904205522600_awaa362-B166","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.crohns.2012.02.021","article-title":"The risk of contracting pediatric inflammatory bowel disease in children with celiac disease, epilepsy, juvenile arthritis and type 1 diabetes\u2013a nationwide study","volume":"7","author":"Virta","year":"2013","journal-title":"J Crohn's Colitis"},{"key":"2021030904205522600_awaa362-B167","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1111\/epi.16282","article-title":"Seizure specificities in patients with antibody-mediated autoimmune encephalitis","volume":"60","author":"Vogrig","year":"2019","journal-title":"Epilepsia"},{"key":"2021030904205522600_awaa362-B168","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000485136","article-title":"Epilepsy among systemic lupus erythematosus patients: insights from a large database analysis","volume":"50","author":"Watad","year":"2018","journal-title":"Neuroepidemiology"},{"key":"2021030904205522600_awaa362-B169","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/epi.13356","article-title":"Neuronal antibodies in pediatric epilepsy: clinical features and long-term outcomes of a historical cohort not treated with immunotherapy","volume":"57","author":"Wright","year":"2016","journal-title":"Epilepsia"},{"key":"2021030904205522600_awaa362-B170","doi-asserted-by":"crossref","first-page":"5047898","DOI":"10.1155\/2017\/5047898","article-title":"Autoantibodies to NR2A peptide of the glutamate\/NMDA receptor in patients with seizure disorders in neuropsychiatric systemic lupus erythematosus","volume":"2017","author":"Yang","year":"2017","journal-title":"Mediators Inflamm"},{"key":"2021030904205522600_awaa362-B171","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/cbf.3113","article-title":"Type 1 diabetes exacerbates blood-brain barrier alterations during experimental epileptic seizures in an animal model","volume":"33","author":"Yorulmaz","year":"2015","journal-title":"Cell Biochem Funct"},{"key":"2021030904205522600_awaa362-B172","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1542\/peds.113.6.1672","article-title":"Range of neurologic disorders in patients with celiac disease","volume":"113","author":"Zelnik","year":"2004","journal-title":"Pediatrics"},{"key":"2021030904205522600_awaa362-B173","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12974-018-1078-8","article-title":"Upregulation of HMGB1-TLR4 inflammatory pathway in focal cortical dysplasia type II","volume":"15","author":"Zhang","year":"2018","journal-title":"J Neuroinflammation"},{"key":"2021030904205522600_awaa362-B174","doi-asserted-by":"crossref","first-page":"S139","DOI":"10.33549\/physiolres.933671","article-title":"Vagal-immune interactions involved in cholinergic anti-inflammatory pathway","volume":"66(Supplementum 2","author":"Zila","year":"2017","journal-title":"Physiol Res"}],"container-title":["Brain"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/brain\/article-pdf\/144\/2\/372\/36454307\/awaa362.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/brain\/article-pdf\/144\/2\/372\/36454307\/awaa362.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,15]],"date-time":"2024-08-15T00:50:52Z","timestamp":1723683052000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/brain\/article\/144\/2\/372\/5998333"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,22]]},"references-count":173,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2020,11,22]]},"published-print":{"date-parts":[[2021,3,3]]}},"URL":"https:\/\/doi.org\/10.1093\/brain\/awaa362","relation":{},"ISSN":["0006-8950","1460-2156"],"issn-type":[{"value":"0006-8950","type":"print"},{"value":"1460-2156","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,2,1]]},"published":{"date-parts":[[2020,11,22]]}}}